Opioid Use Disorder (OUD) Treatment Market Analysis by Size, Share, Growth, Trends and Forecast (2024–2032) | UnivDatos
According to a new report by Univdatos Market Insights, the Opioid Use Disorder (OUD) Treatment Market is expected to reach ~USD 6.5 billion in 2032 by growing at a CAGR of ~8.1%. Opioid Use Disorder (OUD) requires medication, and supportive services for those struggling with addiction since it is a complex disease affecting the brain. Medications like methadone, buprenorphine, and naltrexone alleviate the withdrawal process and provide relief from cravings and opioid effects. Other behavioural therapies such as cognitive behavioural therapy and contingency management seek to change undesirable behaviours as well as incentivize recovery. Counselling, case management, and support groups help individuals continue to abstain from substance use and reintegrate into society. Holistic non-pharmacological approaches that exist include medication-assisted treatment (MAT) programs and OUD treatment strategies that are aimed at providing a rounded and comprehensive solution to treat the disorder.
Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=65210
KEY GROWTH DRIVERS:
The market of OUD treatment is growing very fast due to the opioid crisis and the variety of therapeutic approaches is contributing to this market. This market includes medication-assisted treatments such as methadone, buprenorphine, and naltrexone, which are popular because of their ability to effectively help with withdrawal symptoms and relapse rates. In conjunction with MAT, there are behavioural therapies and psychosocial interventions that enhance the treatment. Market growth can also be attributed to increased population awareness, government involvement, and funding towards the prevention and combating of substance dependency.
· In July 2024, virtual OUD provider Bicycle Health launched a program for teens ages 16 and 17 who live in Maine, offering them virtual treatment and access to evidence-based medications for opioid use disorder (MOUDs).
· In April 2022, Pear Therapeutics launched a program to offer digital therapeutic users access to a telehealth provider. Boston-based Pear’s program offers patients seeking treatment for substance use disorder (SUD) or opioid use disorder (OUD) access to a telehealth provider through its “find a provider tool,” as well as in-person care options.
The report suggests that the Increasing Prevalence of Opioid Use Disorder is a significant factor driving the growth of the opioid use disorder (OUD) treatment market in the coming years. According to the World Health Organization, about 296 million people (or 5.8% of the global population aged 15–64 years) used drugs at least once in 2021. Among them, about 60 million people used opioids. About 39.5 million people lived with drug use disorders in 2021. Growth in the number of opioid users constitutes the leading factor in the OUD treatment market due to the risks that come with opioids. Due to increased opioid addiction, there is a massive public health concern in terms of rising overdose deaths, hospitalizations, and total morbidity related to opioid use. Communities are now dealing with the OE, and so there has been an increased call for interventions that can address and reverse the OP. This has stimulated healthcare providers, policymakers, and pharmaceutical entities to Increase investment in the development of new medication and treatment options more than any other disease crisis in history. The high amount of publicity given to the opioid epidemic; increased healthcare costs; the steady rise in workload for healthcare providers; and the need for new, effective, and affordable therapies to treat opioid addiction and the diseases associated with opioids, propel the market forward.
Parenteral Segment Gaining Maximum Traction in the Market
The parenteral segment in the opioid use disorder (OUD) treatment market has experienced a significant uplift due to the efficacy and the longer span of injectable products. Other drugs like Extended-release Naltrexone (Vivitrol) Series carry a lot of following due to long-lasting opioid Receptor blockers which assist in cravings and help in avoiding relapse period. This segment’s growth is also backed by enhancements in formulation technology as well as the rising endorsement by clinicians related to their superb adherence and effectiveness in addressing OUD. Moreover, the trend to employ multidimensional treatment regimens and patient adherence has also contributed to the strengthening of parenteral treatments for the total management of OUD further boosting its role in the management of OUD.
Click here to view the Report Description & TOC https://univdatos.com/report/opioid-use-disorder-treatment-market/
Conclusion
The global opioid use disorder (OUD) treatment market is rapidly growing, with advancements in the healthcare industry leading to improved outcomes. The global market is expected to increase as new innovative products are developed in the coming years. Thus, the international opioid use disorder (OUD) treatment market represents a significant opportunity for companies to make strategic alliances to launch a diversity of effective medicines. With continued development, more products will likely become available, improving consumer outcomes.
Contact Us:
UnivDatos Market Insights
Email - contact@univdatos.com
Contact Number - +1 9782263411
Website - https://univdatos.com/
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian